Fig. 3From: Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancerSerum CPN1 and CA153 levels in 4 chemotherapy-insensitive patients. A CPN1 levels; B CA153 levels; C–F Levels of CPN1 and CA153 in each chemotherapy-insensitive patientBack to article page